Selected article for: "acute infection and influenza virus"
Author: Broadbent, Andrew J.; Boonnak, Kobporn; Subbarao, Kanta
Title: Respiratory Virus Vaccines
  • Cord-id: dcui85lw
  • Document date: 2015_3_13
    • ID: dcui85lw
    Snippet: This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinic
    Document: This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid inducible gene: 1
    • absence presence and acid residue: 1
    • absence presence and activation result: 1, 2
    • absence presence and active area: 1
    • absence presence and active form: 1, 2
    • absence presence and acute illness: 1, 2, 3, 4, 5, 6
    • absence presence and acute infection result: 1
    • absence presence and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • absence presence and acute response: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absence presence and adaptive immune response: 1, 2
    • absence presence and adaptive innate: 1, 2
    • absence presence and adaptive innate response: 1
    • absence presence and additional research: 1
    • absence presence and adhesion molecule: 1, 2, 3, 4
    • absence presence and administration route: 1
    • absence presence and live vaccine: 1
    • absence presence and low respiratory: 1
    • absence presence and low temperature: 1, 2, 3